{"entity":{"type":"insider","cik":"0001355537","url":"/insider/0001355537","json_url":"/insider/0001355537.json","name":"Polymeropoulos Mihael Hristos","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":147,"n_filings":51,"first":"2006-11-08","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Polymeropoulos Mihael Hristos","source":"filing","n_filings":51,"first_seen":"2006-11-08","last_seen":"2026-03-04"}],"transactions":[{"id":5751036,"accession":"0001355537-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001355537-26-000002","line_url":"/filing/0001355537-26-000002#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":156235.0,"shares_display":"156,235","price_per_share":8.1734,"price_display":"8.17","price_state":"stated","total_value":1276971.149,"total_display":"1,276,971.15","total_whole":"1,276,971","shares_owned_after":2704496.0,"shares_owned_after_display":"2,704,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":4133154,"accession":"0000950170-25-105819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-105819","line_url":"/filing/0000950170-25-105819#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":41500.0,"total_display":"41,500.00","total_whole":"41,500","shares_owned_after":2335731.0,"shares_owned_after_display":"2,335,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-07","filed_date":"2025-08-08","scope":"insider"},{"id":5033381,"accession":"0000950170-25-076012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-076012","line_url":"/filing/0000950170-25-076012","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.399519,"price_display":"4.40","price_state":"stated","total_value":43995.19,"total_display":"43,995.19","total_whole":"43,995","shares_owned_after":2325250.0,"shares_owned_after_display":"2,325,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-21","filed_date":"2025-05-21","scope":"insider","n_lines":2},{"id":4617740,"accession":"0000950170-25-074565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-074565","line_url":"/filing/0000950170-25-074565#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.2236,"price_display":"4.22","price_state":"stated","total_value":84472.0,"total_display":"84,472.00","total_whole":"84,472","shares_owned_after":2315731.0,"shares_owned_after_display":"2,315,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":4834857,"accession":"0000950170-25-034966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-034966","line_url":"/filing/0000950170-25-034966","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.015,"price_display":"5.02","price_state":"stated","total_value":50150.0,"total_display":"50,150.00","total_whole":"50,150","shares_owned_after":2290731.0,"shares_owned_after_display":"2,290,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-06","scope":"insider","n_lines":2},{"id":5031659,"accession":"0000950170-25-033845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-033845","line_url":"/filing/0000950170-25-033845","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":50200.0,"total_display":"50,200.00","total_whole":"50,200","shares_owned_after":2285731.0,"shares_owned_after_display":"2,285,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-05","scope":"insider","n_lines":2},{"id":4980912,"accession":"0000950170-25-032276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-032276","line_url":"/filing/0000950170-25-032276#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.705,"price_display":"4.70","price_state":"stated","total_value":47050.0,"total_display":"47,050.00","total_whole":"47,050","shares_owned_after":2275731.0,"shares_owned_after_display":"2,275,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4790821,"accession":"0000950170-25-030176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-030176","line_url":"/filing/0000950170-25-030176#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":47600.0,"total_display":"47,600.00","total_whole":"47,600","shares_owned_after":2361730.0,"shares_owned_after_display":"2,361,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-02-28","scope":"insider"},{"id":4416485,"accession":"0000950170-25-029059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-029059","line_url":"/filing/0000950170-25-029059#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":47600.0,"total_display":"47,600.00","total_whole":"47,600","shares_owned_after":2351730.0,"shares_owned_after_display":"2,351,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-27","scope":"insider"},{"id":4416475,"accession":"0000950170-25-027860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-027860","line_url":"/filing/0000950170-25-027860","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.765,"price_display":"4.76","price_state":"stated","total_value":47650.0,"total_display":"47,650.00","total_whole":"47,650","shares_owned_after":2341730.0,"shares_owned_after_display":"2,341,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-26","filed_date":"2025-02-26","scope":"insider","n_lines":2},{"id":5073688,"accession":"0000950170-25-027056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-027056","line_url":"/filing/0000950170-25-027056#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.464,"price_display":"4.46","price_state":"stated","total_value":44640.0,"total_display":"44,640.00","total_whole":"44,640","shares_owned_after":2331730.0,"shares_owned_after_display":"2,331,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-25","scope":"insider"},{"id":2066719,"accession":"0000950170-24-027256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-027256","line_url":"/filing/0000950170-24-027256#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24288.0,"shares_display":"24,288","price_per_share":4.1285,"price_display":"4.13","price_state":"stated","total_value":100273.008,"total_display":"100,273.01","total_whole":"100,273","shares_owned_after":1871730.0,"shares_owned_after_display":"1,871,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2066715,"accession":"0000950170-24-027256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027256","line_url":"/filing/0000950170-24-027256#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30884.0,"shares_display":"30,884","price_per_share":4.2438,"price_display":"4.24","price_state":"stated","total_value":131065.5192,"total_display":"131,065.52","total_whole":"131,066","shares_owned_after":1896018.0,"shares_owned_after_display":"1,896,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8288871,"accession":"0001209191-23-016462","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-016462","line_url":"/filing/0001209191-23-016462#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22538.0,"shares_display":"22,538","price_per_share":6.2506,"price_display":"6.25","price_state":"stated","total_value":140876.0228,"total_display":"140,876.02","total_whole":"140,876","shares_owned_after":1476902.0,"shares_owned_after_display":"1,476,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":8288868,"accession":"0001209191-23-016462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016462","line_url":"/filing/0001209191-23-016462#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22426.0,"shares_display":"22,426","price_per_share":6.2302,"price_display":"6.23","price_state":"stated","total_value":139718.4652,"total_display":"139,718.47","total_whole":"139,718","shares_owned_after":1499440.0,"shares_owned_after_display":"1,499,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6549047,"accession":"0001209191-22-060227","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-060227","line_url":"/filing/0001209191-22-060227#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48250.0,"shares_display":"48,250","price_per_share":10.6131,"price_display":"10.61","price_state":"stated","total_value":512082.075,"total_display":"512,082.08","total_whole":"512,082","shares_owned_after":1406866.0,"shares_owned_after_display":"1,406,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-07","scope":"insider"},{"id":6549043,"accession":"0001209191-22-060227","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060227","line_url":"/filing/0001209191-22-060227#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47650.0,"shares_display":"47,650","price_per_share":10.6233,"price_display":"10.62","price_state":"stated","total_value":506200.245,"total_display":"506,200.24","total_whole":"506,200","shares_owned_after":1379751.0,"shares_owned_after_display":"1,379,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-07","scope":"insider"},{"id":6566029,"accession":"0001209191-22-015157","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-015157","line_url":"/filing/0001209191-22-015157#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29588.0,"shares_display":"29,588","price_per_share":11.1513,"price_display":"11.15","price_state":"stated","total_value":329944.6644,"total_display":"329,944.66","total_whole":"329,945","shares_owned_after":1352766.0,"shares_owned_after_display":"1,352,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-02","scope":"insider"},{"id":6566027,"accession":"0001209191-22-015157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015157","line_url":"/filing/0001209191-22-015157#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7508.0,"shares_display":"7,508","price_per_share":11.19,"price_display":"11.19","price_state":"stated","total_value":84014.52,"total_display":"84,014.52","total_whole":"84,015","shares_owned_after":1382354.0,"shares_owned_after_display":"1,382,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":4958065,"accession":"0001209191-21-067592","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-067592","line_url":"/filing/0001209191-21-067592#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46200.0,"shares_display":"46,200","price_per_share":16.0032,"price_display":"16.00","price_state":"stated","total_value":739347.84,"total_display":"739,347.84","total_whole":"739,348","shares_owned_after":1274862.0,"shares_owned_after_display":"1,274,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider"},{"id":4958052,"accession":"0001209191-21-067592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067592","line_url":"/filing/0001209191-21-067592#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.4855,"price_display":"16.49","price_state":"stated","total_value":824275.0,"total_display":"824,275.00","total_whole":"824,275","shares_owned_after":1249386.0,"shares_owned_after_display":"1,249,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider"},{"id":4259961,"accession":"0001209191-21-019118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-019118","line_url":"/filing/0001209191-21-019118#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":18.0003,"price_display":"18.00","price_state":"stated","total_value":3150052.5,"total_display":"3,150,052.50","total_whole":"3,150,053","shares_owned_after":1221062.0,"shares_owned_after_display":"1,221,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-09","scope":"insider"},{"id":4259763,"accession":"0001209191-21-017276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017276","line_url":"/filing/0001209191-21-017276#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15206.0,"shares_display":"15,206","price_per_share":18.3416,"price_display":"18.34","price_state":"stated","total_value":278902.3696,"total_display":"278,902.37","total_whole":"278,902","shares_owned_after":1396062.0,"shares_owned_after_display":"1,396,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider"},{"id":4259760,"accession":"0001209191-21-017276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017276","line_url":"/filing/0001209191-21-017276#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7479.0,"shares_display":"7,479","price_per_share":18.452,"price_display":"18.45","price_state":"stated","total_value":138002.508,"total_display":"138,002.51","total_whole":"138,003","shares_owned_after":1411268.0,"shares_owned_after_display":"1,411,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2146765,"accession":"0001209191-20-063474","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-063474","line_url":"/filing/0001209191-20-063474#line-6","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39150.0,"shares_display":"39,150","price_per_share":12.9973,"price_display":"13.00","price_state":"stated","total_value":508844.295,"total_display":"508,844.30","total_whole":"508,844","shares_owned_after":1303747.0,"shares_owned_after_display":"1,303,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-15","scope":"insider"},{"id":2146759,"accession":"0001209191-20-063474","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-063474","line_url":"/filing/0001209191-20-063474#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51049.0,"shares_display":"51,049","price_per_share":13.1894,"price_display":"13.19","price_state":"stated","total_value":673305.6806,"total_display":"673,305.68","total_whole":"673,306","shares_owned_after":1296234.0,"shares_owned_after_display":"1,296,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":2146753,"accession":"0001209191-20-063474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-063474","line_url":"/filing/0001209191-20-063474#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35053.0,"shares_display":"35,053","price_per_share":12.8765,"price_display":"12.88","price_state":"stated","total_value":451359.9545,"total_display":"451,359.95","total_whole":"451,360","shares_owned_after":1285763.0,"shares_owned_after_display":"1,285,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":2217404,"accession":"0001209191-20-016204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016204","line_url":"/filing/0001209191-20-016204#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5152.0,"shares_display":"5,152","price_per_share":10.9752,"price_display":"10.98","price_state":"stated","total_value":56544.2304,"total_display":"56,544.23","total_whole":"56,544","shares_owned_after":1278999.0,"shares_owned_after_display":"1,278,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-04","scope":"insider"},{"id":2217402,"accession":"0001209191-20-016204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-016204","line_url":"/filing/0001209191-20-016204#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10428.0,"shares_display":"10,428","price_per_share":10.5688,"price_display":"10.57","price_state":"stated","total_value":110211.4464,"total_display":"110,211.45","total_whole":"110,211","shares_owned_after":1284151.0,"shares_owned_after_display":"1,284,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2576416,"accession":"0001209191-20-002031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002031","line_url":"/filing/0001209191-20-002031#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9467.0,"shares_display":"9,467","price_per_share":16.0022,"price_display":"16.00","price_state":"stated","total_value":151492.8274,"total_display":"151,492.83","total_whole":"151,493","shares_owned_after":1234579.0,"shares_owned_after_display":"1,234,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":7873795,"accession":"0001209191-19-060380","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060380","line_url":"/filing/0001209191-19-060380#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70036.0,"shares_display":"70,036","price_per_share":16.982,"price_display":"16.98","price_state":"stated","total_value":1189351.352,"total_display":"1,189,351.35","total_whole":"1,189,351","shares_owned_after":1244046.0,"shares_owned_after_display":"1,244,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-13","scope":"insider"},{"id":7873788,"accession":"0001209191-19-060380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060380","line_url":"/filing/0001209191-19-060380#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72373.0,"shares_display":"72,373","price_per_share":16.9176,"price_display":"16.92","price_state":"stated","total_value":1224377.4648,"total_display":"1,224,377.46","total_whole":"1,224,377","shares_owned_after":1228281.0,"shares_owned_after_display":"1,228,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-13","scope":"insider"},{"id":8100396,"accession":"0001209191-19-031781","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-031781","line_url":"/filing/0001209191-19-031781#line-6","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72872.0,"shares_display":"72,872","price_per_share":15.3413,"price_display":"15.34","price_state":"stated","total_value":1117951.2136,"total_display":"1,117,951.21","total_whole":"1,117,951","shares_owned_after":1211455.0,"shares_owned_after_display":"1,211,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-21","scope":"insider"},{"id":8100387,"accession":"0001209191-19-031781","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-031781","line_url":"/filing/0001209191-19-031781#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67418.0,"shares_display":"67,418","price_per_share":15.1159,"price_display":"15.12","price_state":"stated","total_value":1019083.7462,"total_display":"1,019,083.75","total_whole":"1,019,084","shares_owned_after":1205308.0,"shares_owned_after_display":"1,205,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-21","scope":"insider"},{"id":8100377,"accession":"0001209191-19-031781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-031781","line_url":"/filing/0001209191-19-031781#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77225.0,"shares_display":"77,225","price_per_share":15.5609,"price_display":"15.56","price_state":"stated","total_value":1201690.5025,"total_display":"1,201,690.50","total_whole":"1,201,691","shares_owned_after":1199118.0,"shares_owned_after_display":"1,199,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-17","filed_date":"2019-05-21","scope":"insider"},{"id":8232801,"accession":"0001209191-19-015746","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-015746","line_url":"/filing/0001209191-19-015746#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38166.0,"shares_display":"38,166","price_per_share":19.41,"price_display":"19.41","price_state":"stated","total_value":740802.06,"total_display":"740,802.06","total_whole":"740,802","shares_owned_after":1178970.0,"shares_owned_after_display":"1,178,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-04","scope":"insider"},{"id":8232795,"accession":"0001209191-19-015746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015746","line_url":"/filing/0001209191-19-015746#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":20.219,"price_display":"20.22","price_state":"stated","total_value":131423.5,"total_display":"131,423.50","total_whole":"131,424","shares_owned_after":1217136.0,"shares_owned_after_display":"1,217,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":8230677,"accession":"0001209191-19-001979","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-001979","line_url":"/filing/0001209191-19-001979#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4447.0,"shares_display":"4,447","price_per_share":26.041,"price_display":"26.04","price_state":"stated","total_value":115804.327,"total_display":"115,804.33","total_whole":"115,804","shares_owned_after":1163636.0,"shares_owned_after_display":"1,163,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":8230673,"accession":"0001209191-19-001979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-001979","line_url":"/filing/0001209191-19-001979","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10789.0,"shares_display":"10,789","price_per_share":26.495349893409955,"price_display":"26.50","price_state":"stated","total_value":285858.33,"total_display":"285,858.33","total_whole":"285,858","shares_owned_after":1171139.0,"shares_owned_after_display":"1,171,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":2},{"id":6631914,"accession":"0001209191-18-015887","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-015887","line_url":"/filing/0001209191-18-015887#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60966.0,"shares_display":"60,966","price_per_share":18.7154,"price_display":"18.72","price_state":"stated","total_value":1141003.0764,"total_display":"1,141,003.08","total_whole":"1,141,003","shares_owned_after":1182872.0,"shares_owned_after_display":"1,182,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-02","scope":"insider"},{"id":6195869,"accession":"0001209191-18-002064","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-002064","line_url":"/filing/0001209191-18-002064","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191760.0,"shares_display":"191,760","price_per_share":15.295822460367125,"price_display":"15.30","price_state":"stated","total_value":2933126.915,"total_display":"2,933,126.92","total_whole":"2,933,127","shares_owned_after":1111623.0,"shares_owned_after_display":"1,111,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider","n_lines":2},{"id":4538650,"accession":"0001209191-17-002190","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-002190","line_url":"/filing/0001209191-17-002190#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23330.0,"shares_display":"23,330","price_per_share":15.484,"price_display":"15.48","price_state":"stated","total_value":361241.72,"total_display":"361,241.72","total_whole":"361,242","shares_owned_after":850848.0,"shares_owned_after_display":"850,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2986756,"accession":"0001209191-16-090127","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-090127","line_url":"/filing/0001209191-16-090127#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21353.0,"shares_display":"21,353","price_per_share":8.96,"price_display":"8.96","price_state":"stated","total_value":191322.88,"total_display":"191,322.88","total_whole":"191,323","shares_owned_after":839178.0,"shares_owned_after_display":"839,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider"},{"id":8793902,"accession":"0001209191-15-070343","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-070343","line_url":"/filing/0001209191-15-070343#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355537","owner_name":"Polymeropoulos Mihael Hristos","owner_display_name":"Polymeropoulos Mihael Hristos","owner_url":"/insider/0001355537","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102162.0,"shares_display":"102,162","price_per_share":12.7298,"price_display":"12.73","price_state":"stated","total_value":1300501.8276,"total_display":"1,300,501.83","total_whole":"1,300,502","shares_owned_after":816781.0,"shares_owned_after_display":"816,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"}],"collapsed":true,"next_cursor":"2015-09-10|8793902","ledger_fault":false,"count":{"value":147,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":28,"open_market":true},{"code":"S","label":"Open-market sale","n":119,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":147},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Director, Officer (President and CEO), Other","n_filings":51,"first_seen":"2006-11-08","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001355537","retrieved_at":"2026-08-26T09:06:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}